Autologous hematopoietic recovery after allogeneic hematopoietic stem cell transplantation: A case-based review

被引:0
|
作者
Shi, Xiumin [1 ]
Liu, Xiaoliang [1 ]
Tang, Yang [1 ]
Tan, Yehui [1 ]
Han, Wei [1 ]
Gao, Sujun [1 ,2 ]
机构
[1] First Hosp Jilin Univ, Dept Hematol, Changchun, Peoples R China
[2] 1 Xinmin St, Changchun 130021, Jilin, Peoples R China
关键词
Autologous hematopoietic recovery; Allo-HSCT; MAC; Incidence; Prognosis; CHRONIC MYELOGENOUS LEUKEMIA; SEVERE APLASTIC-ANEMIA; GRAFT FAILURE; LYMPHOCYTE INFUSION; REMISSION; RECONSTITUTION; CYCLOPHOSPHAMIDE; REJECTION; BMT; SCT;
D O I
10.1016/j.trim.2023.101920
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is widely applied for the treatment of hematologic malignancies, but autologous hematopoietic recovery (AR) after allo-HSCT is rare clinically, especially after myeloablative conditioning (MAC). The mechanism of AR remains unclear so far, but the prognosis for most patients is relatively good. Second transplantation is preferred after disease relapse. Starting from a real-life clinical case scenario, herein we reviewed some of the crucial issues of AR in light of recent refinements, and discussed our patients based on the current evidence.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Gemcitabine-Based Salvage Chemotherapy as a Bridge to Allogeneic Hematopoietic Stem Cell Transplantation for the Patients with Relapse of Hodgkin Lymphoma After Autologous Hematopoietic Stem Cell Transplantation
    Czyz, Anna
    Nowicki, Adam
    Gil, Lidia
    Dytfeld, Dominik
    Lojko-Dankowska, Anna
    Styczynski, Jan
    Komarnicki, Mieczyslaw
    BLOOD, 2010, 116 (21) : 1164 - 1164
  • [22] Second allogeneic hematopoietic stem cell transplantation in patients with acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation
    Choi, Yunsuk
    Choi, Eun-Ji
    Lee, Jung-Hee
    Lee, Kyoo-Hyung
    Jo, Jae-Cheol
    Park, Han-Seung
    Lee, Yoo Jin
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Lee, Je-Hwan
    CLINICAL TRANSPLANTATION, 2021, 35 (03)
  • [23] Erythrocytosis after allogeneic hematopoietic stem cell transplantation
    Hino, Yutaro
    Doki, Noriko
    Kurosawa, Shuhei
    Yamamoto, Keita
    Sakaguchi, Masahiro
    Harada, Kaito
    Ikegawa, Shuntaro
    Shingai, Naoki
    Hattori, Kenichiro
    Senoo, Yasushi
    Igarashi, Aiko
    Najima, Yuho
    Kobayashi, Takeshi
    Kakihana, Kazuhiko
    Sakamaki, Hisashi
    Ohashi, Kazuteru
    CLINICAL TRANSPLANTATION, 2017, 31 (04)
  • [24] Jaundice After Allogeneic Hematopoietic Stem Cell Transplantation
    Mendizabal, Manuel
    Chen, Terina
    Reddy, K. Rajender
    HEPATOLOGY, 2009, 50 (06) : 2044 - 2045
  • [25] Rhabdomyolysis After Allogeneic Hematopoietic Stem Cell Transplantation
    Q. Jiang
    B. H. Zhang
    Indian Journal of Hematology and Blood Transfusion, 2016, 32 : 504 - 506
  • [26] Malakoplakia After Allogeneic Hematopoietic Stem Cell Transplantation
    Robinson, Tracy
    Streu, Erin
    ONCOLOGY NURSING FORUM, 2015, 42 (05) : 558 - 561
  • [27] Rhabdomyolysis After Allogeneic Hematopoietic Stem Cell Transplantation
    Jiang, Q.
    Zhang, B. H.
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2016, 32 (04) : 504 - 506
  • [28] Plasticity after allogeneic hematopoietic stem cell transplantation
    Rovo, Alicia
    Gratwohl, Alois
    BIOLOGICAL CHEMISTRY, 2008, 389 (07) : 825 - 836
  • [29] Polyomaviruses After Allogeneic Hematopoietic Stem Cell Transplantation
    Mendoza, Maria Alejandra
    Imlay, Hannah
    VIRUSES-BASEL, 2025, 17 (03):
  • [30] Hyperlipidemia After Allogeneic Hematopoietic Stem Cell Transplantation
    Blaser, Bradley W.
    Kim, Haesook
    Plutzky, Jorge
    Alyea, Edwin, III
    Ho, Vincent
    Cutler, Corey
    Armand, Philippe
    Koreth, John
    Antin, Joseph H.
    Soiffer, Robert
    BLOOD, 2010, 116 (21) : 1419 - 1419